PMID: 11932493Apr 5, 2002Paper

Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides

Protein Engineering
Monali V SawaiBrian F Tack

Abstract

We studied three model antibacterial peptides that resembled the N-terminal 18 amino acids of SMAP-29, an alpha-helical, antimicrobial peptide of sheep. Although the parent compound, ovispirin-1 (KNLRR IIRKI IHIIK KYG), was potently antimicrobial, it was also highly cytotoxic to human epithelial cells and hemolytic for human erythrocytes. Single residue substitutions to ovispirin-1 yielded two substantially less cytotoxic peptides (novispirins), with intact antimicrobial properties. One of these, novispirin G-10, differed from ovispirin-1 only by containing glycine at position 10, instead of isoleucine. The other, novispirin T-7, contained threonine instead of isoleucine at position 7. We determined the three-dimensional solution structures of all three peptides by circular dichroism spectroscopy and two-dimensional nuclear magnetic resonance spectroscopy. Although all retained an amphipathic helical structure in 2,2,2-trifluoroethanol, they manifested subtle fine-structural changes that evidently impacted their activities greatly. These findings show that simple structural modifications can 'fine-tune' an antimicrobial peptide to minimize unwanted cytotoxicity while retaining its desired activity.

References

Mar 21, 1991·Journal of Immunological Methods·R I LehrerP Eisenhauer
Jan 1, 1984·Annual Review of Biochemistry·D Eisenberg
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·B AgerberthG H Gudmundsson
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·G H GudmundssonH G Boman
Jul 17, 1995·FEBS Letters·C ZhaoR I Lehrer
Feb 1, 1996·Journal of Molecular Graphics·R KoradiK Wüthrich
Nov 21, 1997·Journal of Molecular Biology·P GüntertK Wüthrich
Jan 15, 1998·European Journal of Biochemistry·A TossiD Romeo
Nov 7, 1998·Biochimica Et Biophysica Acta·K Matsuzaki
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M G ScottM R Gold
Apr 18, 2000·Infection and Immunity·S M TravisB F Tack
Jul 18, 2000·Advances in Experimental Medicine and Biology·M ZanettiB Skerlavaj
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·V C KalfaK A Brogden

❮ Previous
Next ❯

Citations

Mar 17, 2004·Peptides·Jon-Paul S Powers, Robert E W Hancock
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ioannis GryllosMichael R Wessels
Oct 25, 2012·The Journal of Biological Chemistry·Jesper S OeemigReinhard Wimmer
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·Christopher W KaplanRandal Eckert
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Jian HeWenyuan Shi
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Karen H BartlettPeter S Thorne
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Randal EckertWenyuan Shi
Jan 14, 2004·American Journal of Respiratory and Critical Care Medicine·D Michael Shasby, Paul McCray
Feb 2, 2013·PloS One·Valeriy DomenyukChris W Diehnelt
Nov 3, 2011·PLoS Pathogens·Hien J Tran-WinklerMichael R Wessels
Feb 1, 2011·Expert Opinion on Drug Discovery·Håvard Jenssen
Jul 12, 2011·International Journal of Antimicrobial Agents·Raymond M DawsonChun-Qiang Liu
Jul 8, 2011·International Journal of Antimicrobial Agents·Nicole K Brogden, Kim A Brogden
Jul 15, 2004·The Journal of Peptide Research : Official Journal of the American Peptide Society·B YasinE A Wagar
Aug 23, 2006·Chemical Biology & Drug Design·Olivier TaboureauHans-Henrik Kristensen
Feb 19, 2008·Oral Microbiology and Immunology·P L WeistrofferJ M Guthmiller
Jan 18, 2005·International Journal of Pharmaceutics·Walaisiri MuangsiriLee E Kirsch
Oct 12, 2004·Burns : Journal of the International Society for Burn Injuries·L SteinstraesserH U Steinau
Jun 15, 2004·International Journal of Antimicrobial Agents·Karen H BartlettPeter S Thorne
Jan 16, 2007·Biophysical Journal·Martin B UlmschneiderAlfredo Di Nola
Jun 7, 2006·Biochimica Et Biophysica Acta·Himanshu KhandeliaYiannis N Kaznessis
Dec 13, 2005·Biophysical Journal·Martin B UlmschneiderAlfredo Di Nola
Aug 5, 2015·Journal of the American Chemical Society·Bei DingZhan Chen
Mar 25, 2008·Biochimica Et Biophysica Acta·Himanshu KhandeliaOle G Mouritsen
Nov 16, 2013·The Journal of Physical Chemistry. B·Bei DingZhan Chen
Feb 9, 2010·Journal of the American Chemical Society·Ann Marie WoysMartin T Zanni
Aug 19, 2009·Chembiochem : a European Journal of Chemical Biology·Magnus FranzmannReinhard Wimmer
Feb 16, 2019·Current Protein & Peptide Science·Marian VincenziMarilisa Leone
Jun 24, 2018·Pharmaceutics·Ilaria PassariniMire Zloh
Mar 28, 2019·Scientific Reports·Piyush AgrawalIndrakant K Singh
Jan 17, 2019·The Journal of Chemical Physics·Megan K PettiMartin T Zanni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.